Hims & Hers Health, Inc.
HIMS
$58.55
-$2.66-4.35%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 110.67% | 95.09% | 77.13% | 51.82% | 45.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 110.67% | 95.09% | 77.13% | 51.82% | 45.81% |
| Cost of Revenue | 216.49% | 162.21% | 112.41% | 56.37% | 31.41% |
| Gross Profit | 88.00% | 81.10% | 69.71% | 50.81% | 49.32% |
| SG&A Expenses | 67.50% | 71.89% | 49.47% | 35.41% | 32.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.39% | 87.93% | 61.18% | 40.28% | 33.03% |
| Operating Income | 494.28% | 762.96% | 361.56% | 219.42% | 192.10% |
| Income Before Tax | 387.74% | 915.07% | 441.14% | 287.22% | 228.12% |
| Income Tax Expenses | 763.53% | -492.64% | -8,086.94% | 1,076.92% | 230.31% |
| Earnings from Continuing Operations | 344.69% | 1,990.36% | 1,098.92% | 285.79% | 210.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 344.69% | 1,990.36% | 1,098.92% | 285.79% | 210.54% |
| EBIT | 494.28% | 762.96% | 361.56% | 219.42% | 192.10% |
| EBITDA | 420.63% | 442.97% | 532.19% | 313.92% | 248.89% |
| EPS Basic | 327.83% | 1,913.56% | 1,069.17% | 280.76% | 207.20% |
| Normalized Basic EPS | 377.53% | 387.01% | 430.58% | 281.86% | 230.82% |
| EPS Diluted | 313.81% | 1,830.36% | 993.33% | 265.01% | 199.79% |
| Normalized Diluted EPS | 361.47% | 363.95% | 404.37% | 266.05% | 221.86% |
| Average Basic Shares Outstanding | 4.00% | 3.52% | 3.08% | 2.97% | 3.05% |
| Average Diluted Shares Outstanding | 7.52% | 8.51% | 11.87% | 12.65% | 10.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |